ÂÜÀòÂÒÂ×

Sudhir Joshi is an accomplished business development professional with extensive experience in the biosciences sector. Currently serving as Head of Business Development at BioGenomics Ltd. since July 2013, Sudhir focuses on licensing late-stage biosimilar assets in Diabetes, Oncology, and Infectious Diseases, alongside managing global sales of Recombinant AOF enzymes. Previously, at Avesthagen from October 2006 to June 2013, Sudhir successfully licensed early and late-stage biosimilar products in emerging markets, notably securing an exclusive licensing transaction for a mammalian biosimilar. Sudhir's career commenced at Amersham Biosciences as a Product Executive and included a role at MILLIPORE (India) Pvt. Ltd. as Senior Specialist in Application Engineering and Process Development Services, where support was provided to biotech customers across India. Education was completed at Kendriya Vidyalaya.